PODDInsulet Corporation

Health care · Medical Instruments · Nasdaq

Insulet Corporation (“we” or the “Company”) is primarily engaged in the development, manufacture, and sale of its proprietary continuous insulin delivery systems for people with insulin-dependent diabetes. 10-K, Item 1

Employees: 5,400
Headquarters: Acton, MA
CEO: Ashley McEvoy
Next results: around Feb 17, 2027

Compare with peers → Embed

Every trade in PODD shares that directors, officers and 10% owners reported on Form 4 since May 14, 2026. Open-market buys and sales are the trades the insider chose to make; grants, option exercises and shares withheld for tax are part of pay.

Bought on the market $1.1M 3 trades by 3 insiders

Sold on the market $60K 1 trade by 1 insider

All Buys and sales Buys Sales

Date	Insider	Role	Type	Shares	Price	Value	Owned after
Aug 21, 2026	Ashley McEvoy	President and CEO, Director	Buy	1,100	147.47	162K	23,731
Jun 3, 2026	Elizabeth H. Weatherman	Director	Buy	3,450	144.20	497K	10,352
Jun 3, 2026	Luciana Borio	Director	Sale	-418	143.27	60K	4,329
Jun 3, 2026	Timothy C. Stonesifer	Director	Buy	2,790	143.51	400K	9,041

From the Form 4s in SEC's filing index; each date links to the filing. The Insider selling plans tab shows planned sales (10b5-1 plans and Form 144).

Work on PODD in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/PODD/export.csv") into a cell.